Full cycle

CF ON3 Lifesciences Parent DST Reached Full Cycle Through a Section 721 UPREIT Roll in February 2026

Cantor Fitzgerald's published track record is where the completion appears, closing a hold the disposition record puts at 3. 7 years from the offering's first Form D.

Published Updated

CF ON3 Lifesciences Parent DST completed a Section 721 UPREIT roll in February 2026, contributing its interests to a real estate investment trust in exchange for operating-partnership units. That is the mechanism the disposition record states: the form of exit in which a Delaware Statutory Trust (DST) interest in real property becomes an interest in a REIT's operating partnership rather than cash from a sale.

As originally filed


Sponsor

Cantor Fitzgerald

Asset class

Other Real Estate

Exemption

506(b)

Offering ceiling

$69,800,000

Minimum investment

$250,000

First Form D filing

May 23, 2022

The disposition record does not name the REIT that received the contributed interests, and it states no value for the transaction. No total return, annualized return, or equity multiple is on the record for the outcome.